Similar Search Results

How patenting informs VC investors – The case of biotechnology

Haeussler, Carolin; Harhoff, Dietmar; Mueller, Elisabeth - In: Research Policy 43 (2014) 8, pp. 1286-1298

In the presence of asymmetric information, economic agents need to communicate their quality to investors and other parties. This paper investigates how information generated during the patenting process affects the ability of new ventures to attract VC financing. While much of the literature on...

Persistent link: https://www.econbiz.de/10010906506

Does governmental venture capital spur invention and innovation? Evidence from young European biotech companies

Bertoni, Fabio; Tykvová, Tereza - In: Research Policy 44 (2015) 4, pp. 925-935

This paper explores whether and how governmental venture capital investors (GVCs) spur invention and innovation in young biotech companies in Europe. To gauge invention we focus on the simple patent stock at the company level, while innovation is proxied by the citation-weighted patent stock....

Persistent link: https://www.econbiz.de/10011263824

When publications lead to products: The open science conundrum in new product development

Jong, Simcha; Slavova, Kremena - In: Research Policy 43 (2014) 4, pp. 645-654

innovation performance and R&D activities of 160 UK therapeutic biotechnology firms over the period 1998- 2009. Our results from …

Persistent link: https://www.econbiz.de/10010753186

Public funds and local biotechnology firm creation

Kolympiris, Christos; Kalaitzandonakes, Nicholas; … - In: Research Policy 43 (2014) 1, pp. 121-137

births in the context of the U.S. biotechnology industry. In doing so, we introduce a number of changes that strengthen the … Health towards biotechnology associate with increases in the number of biotechnology firm births at the Metropolitan …

Persistent link: https://www.econbiz.de/10010869315

When birds of a feather don’t flock together: Different scientists and the roles they play in biotech R&D alliances

Subramanian, Annapoornima M.; Lim, Kwanghui; Soh, Pek-Hooi - In: Research Policy 42 (2013) 3, pp. 595-612

. Using a panel dataset of 222 firms in biotechnology between 1990 and 2000, we show that bridging scientists have a positive …

Persistent link: https://www.econbiz.de/10010636131

Positions and rewards: The allocation of resources within a science-based entrepreneurial firm

Liu, Christopher C.; Stuart, Toby - In: Research Policy 43 (2014) 7, pp. 1134-1143

We study the link between resource allocation and employee publication in the open science in a quantitative case study of one science-based, entrepreneurial firm. We bridge the literature on incentives with that on authority structures to argue that a positive relationship between rewards and...

Persistent link: https://www.econbiz.de/10010785079

The diminishing signaling value of patents between early rounds of venture capital financing

Hoenen, Sebastian; Kolympiris, Christos; Schoenmakers, … - In: Research Policy 43 (2014) 6, pp. 956-989

580 U.S.-based biotechnology firms to empirically demonstrate that biotechnology firms that have submitted patent … and with insights that can be employed by managers of firms in knowledge intensive areas such as biotechnology. …

Persistent link: https://www.econbiz.de/10010776716

When does tapping external sources of knowledge result in knowledge integration?

Tzabbar, Daniel; Aharonson, Barak S.; Amburgey, Terry L. - In: Research Policy 42 (2013) 2, pp. 481-494

activities by 456 dedicated U.S. biotechnology firms between 1973 and 2003, this article shows that the rate of knowledge …

Persistent link: https://www.econbiz.de/10010616979

Spatial collocation and venture capital in the US biotechnology industry

Kolympiris, Christos; Kalaitzandonakes, Nicholas; … - In: Research Policy 40 (2011) 9, pp. 1188-1199

Biotechnology firms operate in a high-risk and high-reward environment and are in a constant race to secure venture … their investments and to provide operating assistance to their target firms. Further, biotechnology is a knowledge … spatial extent of the relationships among the amount of funds raised by proximate biotechnology firms. We model these …

Persistent link: https://www.econbiz.de/10010572675

Institutional entrepreneurship in constructing alternative paths: A comparison of biotech hybrids

DiVito, Lori - In: Research Policy 41 (2012) 5, pp. 884-896

environments. It is a comparative case study of Dutch and British dedicated biotechnology firms focusing on a particular type of …-risk innovation strategies. The Dutch hybrid model offers insight into how firms comply with the dominant logic of the biotechnology …

Persistent link: https://www.econbiz.de/10010572685